ArticleDiscover oncology2026

Immune-related hallmark pathway heterogeneity identifies a prognostic risk signature with independent external validation in glioblastoma.

Ahmed M Abdelmaguid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.